Medication adherence: Pharmacist perspective

Journal of the American Pharmacists Association

Volumn 50, Issue 3, 2010, Pages 394-406

  Bubalo, Joseph ^a   Clark Jr , Roger K ^a   Jiing, Susie S ^b   Johnson, Nathan B ^a   Miller, Katherine A ^a   Clemens Shipman, Colleen J ^a   Sweet, Amanda L ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

Medication adherence; Persistence (medication); Pharmacists

Indexed keywords

PRESCRIPTION DRUG;

AGE; CHRONIC DISEASE; CONSUMER HEALTH INFORMATION; DRUG ADMINISTRATION; DRUG ADMINISTRATION ROUTE; HOMELESSNESS; HUMAN; MENTAL HEALTH; PATIENT COMPLIANCE; PATIENT EDUCATION; POLYPHARMACY; REVIEW;

AGE FACTORS; CHRONIC DISEASE; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; HEALTH LITERACY; HOMELESS PERSONS; HUMANS; MEDICATION ADHERENCE; MENTAL HEALTH; PATIENT EDUCATION AS TOPIC; POLYPHARMACY; PRESCRIPTION DRUGS;

EID: 77955290065     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.08180     Document Type: Review

References (70)

1. Chisholm-Burns MA, Spivey CA. Pharmacoadherence: a new term for a significant problem. Am J Health Syst Pharm. 2008;65:661-7.
2. Hughes D, Cowell W, Koncz T, et al. Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations. Value Health. 2007;10:498-509.
3. Burkhart PV, Sabate E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35:207.
4. Vrijens B, Gross R, Urquhart J. The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analyses. Basic Clin Pharmacol Toxicol. 2005;96:225-7.
5. MacLaughlin EJ, Raehl CL, Treadway AK, et al. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging. 2005;22:231-55.
6. Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci. 2008;53:1020-4.
7. Dimatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200-9.
8. LaFleur J, Oderda GM. Methods to measure patient compliance with medication regimens. J Pain Palliat Care Pharmacother. 2004;18:81-7.
9. Cramer JA, Benedict A, Muszbek N, et al. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62:76-87.
10. Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15:565-74.
11. Kruk ME, Schwalbe N. The relation between intermittent dosing and adherence: preliminary insights. Clin Ther. 2006;28:1989-95.
12. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074-90.
13. Lawrence DB, Allison W, Chen JC, et al. Improving medication adherence with a targeted, technology-driven disease management intervention. Dis Manag. 2008;11:141-4.
14. Chia LR, Schlenk EA, Dunbar-Jacob J. Effect of personal and cultural beliefs on medication adherence in the elderly. Drugs Aging. 2006;23:191-202.
15. Depp CA, Moore DJ, Patterson TL, et al. Psychosocial interventions and medication adherence in bipolar disorder. Dialogues Clin Neurosci. 2008;10:239-50.
16. Morris LS, Schulz RM. Medication compliance: the patient's perspective. Clin Ther. 1993;15:593-606.
17. Murphy PW, Davis TC. When low literacy blocks compliance. RN. 1997;60:58-63.
18. Lash TL, Fox MP, Westrup JL, et al. Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat. 2006;99:215-20.
19. Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001;24:183-97.
20. Rosenbaum JF, Zajecka J. Clinical management of antidepressant discontinuation. J Clin Psychiatry. 1997;58(suppl 7):37-40.
21. Kimmel SE, Chen Z, Price M, et al. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (INRANGE) Study. Arch Intern Med. 2007;167:229-35.
22. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296-310.
23. Boyle BA, Jayaweera D, Witt MD, et al. Randomization to oncedaily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression. HIV Clin Trials. 2008;9:164-76.
24. Murray MD, Morrow DG, Weiner M, et al. A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother. 2004;2:36-43.
25. Kennedy J, Tuleu I, Mackay K. Unfilled prescriptions of Medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008;14:553-60.
26. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, healthrelated quality of life, and health care costs. Pharmacotherapy. 2000;20:941-9.
27. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31:199-205.
28. Zhou SF. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab. 2008;9:310-22.
29. Cipro [package insert]. West Haven, CT: Bayer; 2008.
30. Sandimmune [package insert]. Stein, Switzerland: Novartis; 2008.
31. Fosamax [package insert]. Whitehouse Station, NJ: Merck; 2006.
32. Gold DT, Alexander IM, Ettinger MP. How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy. Ann Pharmacother. 2006;40:1143-50.
33. Shah NR, Hirsch AG, Zacker C, et al. Predictors of first-fill adherence for patients with hypertension. Am J Hypertens. 2009;22:392-6.
34. Chapman RH, Petrilla AA, Benner JS, et al. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study. Drugs Aging. 2008;25:885-92.
35. David C. Preventive therapy for asthmatic children under Florida Medicaid: changes during the 1990s. J Asthma. 2004;41:655-61.
36. Vrijens B, Goetghebeur E, de Klerk E, et al. Modelling the association between adherence and viral load in HIV-infected patients. Stat Med. 2005;24:2719-31.
37. Meyer ME, Schuna AA. Assessment of geriatric patients' functional ability to take medication. DICP. 1989;23:171-4.
38. Depp CA, Cain AE, Palmer BW, et al. Assessment of medication management ability in middle-aged and older adults with bipolar disorder. J Clin Psychopharmacol. 2008;28:225-9.
39. Kreyenbuhl J, Dixon LB, McCarthy JF, et al. Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia? Schizophr Bull. 2010;36:428-35.
40. Roe CM, Motheral BR, Teitelbaum F, et al. Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization. Am J Health Syst Pharm. 2000;57:139-45.
41. Ennis KJ, Reichard RA. Maximizing drug compliance in the elderly: tips for staying on top of your patients' medication use. Postgrad Med. 1997;102:211-4.
42. Taddeo D, Egedy M, Frappier JY. Adherence to treatment in adolescents. Paediatr Child Health. 2008;13:19-24.
43. Butler DA, Zuehlke JB, Tovar A, et al. The impact of modifiable family factors on glycemic control among youth with type 1 diabetes. Pediatr Diabetes. 2008;9:373-81.
44. Gau SS, Shen HY, Chou MC, et al. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol. 2006;16:286-97.
45. Andrus MR, Roth MT. Health literacy: a review. Pharmacotherapy. 2002;22:282-302.
46. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. Health literacy: report of the Council on Scientific Affairs. JAMA. 1999;281:552-7.
47. Cooper JK, Love DW, Raffoul PR. Intentional prescription nonadherence (noncompliance) by the elderly. J Am Geriatr Soc. 1982;30:329-33.
48. Horne R, Graupner L, Frost S, et al. Medicine in a multi-cultural society: the effect of cultural background on beliefs about medications. Soc Sci Med. 2004;59:1307-13.
49. Siegel K, Karus D, Schrimshaw EW. Racial differences in attitudes toward protease inhibitors among older HIV-infected men. AIDS Care. 2000;12:423-34.
50. Hanchak NA, Patel MB, Berlin JA, et al. Patient misunderstanding of dosing instructions. J Gen Intern Med. 1996;11:325-8.
51. Morrell RW, Park DC, Poon LW. Effects of labeling techniques on memory and comprehension of prescription information in young and old adults. J Gerontol. 1990;45:166-72.
52. Paris W, Dunham S, Sebastian A, et al. Medication nonadherence and its relation to financial restriction. J Transpl Coord. 1999;9:149-52.
53. Schoen MD, DiDomenico RJ, Connor SE, et al. Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease. Pharmacotherapy. 2001;21:1455-63.
54. Rudd P, Byyny RL, Zachary V, et al. The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther. 1989;46:169-76.
55. Paes AH, Bakker A, Soe-Agnie CJ. Measurement of patient compliance. Pharm World Sci. 1998;20:73-7.
56. Matsuyama JR, Mason BJ, Jue SG. Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts. Ann Pharmacother. 1993;27:851-5.
57. Winland-Brown JE, Valiante J. Effectiveness of different medication management approaches on elders' medication adherence. Outcomes Manag Nurs Pract. 2000;4:172-6.
58. Cherry JC, Moffatt TP, Rodriguez C, et al. Diabetes disease management program for an indigent population empowered by telemedicine technology. Diabetes Technol Ther. 2002;4:783-91.
59. Claxton A, de Klerk E, Parry M, et al. Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder. J Clin Psychiatry. 2000;61:928-32.
60. Recker RR, Gallagher R, MacCosbe PE. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc. 2005;80:856-61.
61. Archer DF, Bigrigg A, Smallwood GH, et al. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. Fertil Steril. 2002;77(2 suppl 2):S27-31.
62. Oddsson K, Leifels-Fischer B, de Melo NR, et al. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. Contraception. 2005;71:176-82.
63. van Eijken M, Tsang S, Wensing M, et al. Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging. 2003;20:229-40.
64. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;CD000011.
65. Willey C, Redding C, Stafford J, et al. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther. 2000;22:858-71.
66. Ficke DL, Farris KB. Use of the transtheoretical model in the medication use process. Ann Pharmacother. 2005;39:1325-30.
67. Painter JE, Borba CP, Hynes M, et al. The use of theory in health behavior research from 2000 to 2005: a systematic review. Ann Behav Med. 2008;35:358-62.
68. Prochaska JO, Velicer WF. Misinterpretations and misapplications of the transtheoretical model. Am J Health Promot. 1997;12:11-2.
69. Edelberg HK, Shallenberger E, Wei JY. Medication management capacity in highly functioning community-living older adults: detection of early deficits. J Am Geriatr Soc. 1999;47:592-6.
70. Raehl CL, Bond CA, Woods T, et al. Individualized drug use assessment in the elderly. Pharmacotherapy. 2002;22:1239-48.